Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder Cancer

Clinical trial NCT07756008 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07756008
Sponsor: Tianjin Medical University Second Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Bladder Urothelial Carcinoma Muscle-invasive Bladder Cancer Bladder Cancer

Start date: 2026-08-01
Primary completion: 2029-06-20
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.